In contrast to in vivo tumor-derived moDCs and M-MDSCs, FasL was not upregulated upon TCM treatment, suggesting that, while the in vitro culture system mimics the in vivo development of suppressive myeloid populations, the mechanisms that mediate T cell suppression vary between the systems. This evidence concerns the gene FASLG and neoplasm.